BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 29298724)

  • 1. Brainstem tau pathology in Alzheimer's disease is characterized by increase of three repeat tau and independent of amyloid β.
    Uematsu M; Nakamura A; Ebashi M; Hirokawa K; Takahashi R; Uchihara T
    Acta Neuropathol Commun; 2018 Jan; 6(1):1. PubMed ID: 29298724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions.
    Togo T; Akiyama H; Iseki E; Uchikado H; Kondo H; Ikeda K; Tsuchiya K; de Silva R; Lees A; Kosaka K
    Acta Neuropathol; 2004 Jun; 107(6):504-8. PubMed ID: 15024583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibrillary changes undergoing morphological and biochemical changes - How does tau with the profile shift of from four repeat to three repeat spread in Alzheimer brain?
    Uchihara T
    Neuropathology; 2020 Oct; 40(5):450-459. PubMed ID: 32698244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory performance is related to amyloid and tau pathology in the hippocampus.
    Reitz C; Honig L; Vonsattel JP; Tang MX; Mayeux R
    J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):715-21. PubMed ID: 19258354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of caspase-6 in aging and mild cognitive impairment.
    Albrecht S; Bourdeau M; Bennett D; Mufson EJ; Bhattacharjee M; LeBlanc AC
    Am J Pathol; 2007 Apr; 170(4):1200-9. PubMed ID: 17392160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualization of newly deposited tau in neurofibrillary tangles and neuropil threads.
    Miyasaka T; Watanabe A; Saito Y; Murayama S; Mann DM; Yamazaki M; Ravid R; Morishima-Kawashima M; Nagashima K; Ihara Y
    J Neuropathol Exp Neurol; 2005 Aug; 64(8):665-74. PubMed ID: 16106214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
    Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
    J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.
    Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM
    Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Argyrophilic grains are not always argyrophilic--distinction from neurofibrillary tangles of diffuse neurofibrillary tangles with calcification revealed by comparison between Gallyas and Campbell-Switzer methods.
    Uchihara T; Tsuchiya K; Nakamura A; Akiyama H
    Acta Neuropathol; 2005 Aug; 110(2):158-64. PubMed ID: 15971055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
    Streit WJ; Braak H; Xue QS; Bechmann I
    Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silver staining profiles distinguish Pick bodies from neurofibrillary tangles of Alzheimer type: comparison between Gallyas and Campbell-Switzer methods.
    Uchihara T; Tsuchiya K; Nakamura A; Akiyama H
    Acta Neuropathol; 2005 May; 109(5):483-9. PubMed ID: 15759128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to demix Alzheimer-type and PSP-type tau lesions out of their mixture -hybrid approach to dissect comorbidity.
    Ebashi M; Ito Y; Uematsu M; Nakamura A; Hirokawa K; Kamei S; Uchihara T
    Acta Neuropathol Commun; 2019 May; 7(1):71. PubMed ID: 31060611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical investigation of neurofibrillary tangles and their tau isoforms in brains of limbic neurofibrillary tangle dementia.
    Iseki E; Yamamoto R; Murayama N; Minegishi M; Togo T; Katsuse O; Kosaka K; Akiyama H; Tsuchiya K; de Silva R; Andrew L; Arai H
    Neurosci Lett; 2006 Sep; 405(1-2):29-33. PubMed ID: 16859829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau pathology in diffuse neurofibrillary tangles with calcification (DNTC): biochemical and immunohistochemical investigation.
    Tanabe Y; Ishizu H; Ishiguro K; Itoh N; Terada S; Haraguchi T; Kawai K; Kuroda S
    Neuroreport; 2000 Aug; 11(11):2473-7. PubMed ID: 10943706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer's disease-related cytoskeletal pathology.
    Rüb U; Del Tredici K; Schultz C; Thal DR; Braak E; Braak H
    Acta Neuropathol; 2001 Jun; 101(6):555-64. PubMed ID: 11515783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of proteins related neurodegeneration in autopsy brains of the aged].
    Zhu M; Meng X; Wang L; Hu Y; Zhang H; Han Z
    Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):651-6. PubMed ID: 25567589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.
    Hara M; Hirokawa K; Kamei S; Uchihara T
    Acta Neuropathol; 2013 Apr; 125(4):565-79. PubMed ID: 23407988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.